191 related articles for article (PubMed ID: 12874976)
1. Commercializing biotechnology in the UK.
Searle S; Graves B; Towler C
Nat Biotechnol; 2003 Jul; 21 Suppl():BE33-5. PubMed ID: 12874976
[No Abstract] [Full Text] [Related]
2. Marketing biotechnology with a Gallic flair.
Jouanneau AC
Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
[No Abstract] [Full Text] [Related]
3. U2B: a new model for technology transfer.
Gross CM
Nat Biotechnol; 2003 Jul; 21 Suppl():BE31-2. PubMed ID: 12874975
[No Abstract] [Full Text] [Related]
4. Calling for entrepreneurs: London.
Smaglik P
Nat Biotechnol; 2002 Dec; 20(12):1281-2. PubMed ID: 12454679
[No Abstract] [Full Text] [Related]
5. The public-private structure of intellectual property ownership in agricultural biotechnology.
Graff GD; Cullen SE; Bradford KJ; Zilberman D; Bennett AB
Nat Biotechnol; 2003 Sep; 21(9):989-95. PubMed ID: 12949559
[No Abstract] [Full Text] [Related]
6. Private company profiles.
Nat Biotechnol; 2003 Jul; 21 Suppl():BE23-8. PubMed ID: 12874973
[No Abstract] [Full Text] [Related]
7. Earlier stage biotechs attract partners.
Ratner M
Nat Biotechnol; 2005 May; 23(5):509. PubMed ID: 15877052
[No Abstract] [Full Text] [Related]
8. Start-ups: A sense of enterprise.
Savage N
Nature; 2016 May; 533(7601):S10-2. PubMed ID: 27144602
[No Abstract] [Full Text] [Related]
9. Cuba--innovation through synergy.
Thorsteinsdóttir H; Sáenz TW; Quach U; Daar AS; Singer PA
Nat Biotechnol; 2004 Dec; 22 Suppl():DC19-24. PubMed ID: 15583679
[No Abstract] [Full Text] [Related]
10. Technology transfer and idea commercialization.
Sheft J
Nat Biotechnol; 2008 Jun; 26(6):711-2. PubMed ID: 18536695
[No Abstract] [Full Text] [Related]
11. Filters for preparing to meet a venture capitalist.
Christoffersen R
Nat Biotechnol; 2003 Jul; 21 Suppl():BE49-50. PubMed ID: 12874981
[No Abstract] [Full Text] [Related]
12. Convincing a venture capitalist to invest in your idea.
Dooley JF; Dooley JF
Nat Biotechnol; 2003 Jul; 21 Suppl():BE45-8. PubMed ID: 12874980
[No Abstract] [Full Text] [Related]
13. Q&A: Horst Domdey.
Wald C
Nature; 2016 May; 533(7601):S30-1. PubMed ID: 27144606
[No Abstract] [Full Text] [Related]
14. Investing in nanotechnology.
Paull R; Wolfe J; Hébert P; Sinkula M
Nat Biotechnol; 2003 Oct; 21(10):1144-7. PubMed ID: 14520393
[No Abstract] [Full Text] [Related]
15. University spin-offs: opportunity or challenge?
Peng X
Nat Mater; 2006 Dec; 5(12):923-5. PubMed ID: 17139301
[No Abstract] [Full Text] [Related]
16. US venture capital for biotechnology.
Dibner MD; Trull M; Howell M
Nat Biotechnol; 2003 Jun; 21(6):613-7. PubMed ID: 12776144
[No Abstract] [Full Text] [Related]
17. Selling out.
Martin JF
Nat Biotechnol; 2010 Apr; 28(4):315-7. PubMed ID: 20383912
[No Abstract] [Full Text] [Related]
18. Mixed results in Q1.
Lawrence S
Nat Biotechnol; 2005 May; 23(5):518. PubMed ID: 15877059
[No Abstract] [Full Text] [Related]
19. Enthusiasm cools in Q2.
Lawrence S
Nat Biotechnol; 2005 Aug; 23(8):914. PubMed ID: 16082352
[No Abstract] [Full Text] [Related]
20. Profile: Julian Thurston.
Louët S
Nat Biotechnol; 2005 May; 23(5):517. PubMed ID: 15877058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
